Carbogen Amcis Enhances Stability Studies Capacity

Swiss-based Carbogen Amcis, has expanded its service portfolio and capacity for stability studies. In compliance with the latest International Conference on Harmonization (ICH) guidelines, and in response to customer demand, the company has installed new stability chambers at the Hunzenschwil (Neuland), Switzerland operations and offers short-term, long-term, accelerated, intermediate, follow-up and customized tests.

Carbogen Amcis' new fully validated and mapped stability chambers operate at ICH conditions (25°C/60% RH, 30°C/65% RH, and 40°C/75% RH) and at low temperatures (5°C, -20°C and -80°C). With a current shelf storage capacity of about 92 m2, they provide secure and safe storage for API  samples, including highly potent material, employed for in-house stability studies.

"We are facing an increasing customer demand for stability studies, as a stand-alone service or tied to our API development and production efforts," Brian O'Neill, Carbogen Amcis sales manager, said.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.